Literature DB >> 8250038

Independent origin of identical beta cardiac myosin heavy-chain mutations in hypertrophic cardiomyopathy.

H Watkins1, L Thierfelder, R Anan, J Jarcho, A Matsumori, W McKenna, J G Seidman, C E Seidman.   

Abstract

The origins of the beta cardiac myosin heavy-chain (MHC) gene missense mutations that cause familial hypertrophic cardiomyopathy (FHC) in 14 families have been evaluated. Of eight different mutations, four were present in single families, while four occurred in two or more families. To investigate the origins of the four shared mutations, we defined the beta cardiac MHC haplotypes of each of the mutation-bearing chromosomes by determining the alleles present at three intragenic polymorphic loci. Two of the mutations (Arg453Cys and Val606Met) have arisen independently in each of three families, being found on different chromosomal backgrounds. A third mutation (Gly584Arg) is associated with identical haplotypes in two families with Portuguese ancestors, suggesting a founder effect. Haplotype analysis was uninformative for the fourth mutation (Arg403Gln). Thus, FHC-causing mutations have arisen independently in at least 12 of the 14 families studied, suggesting that the majority have arisen relatively recently as new mutations. This finding predicts the prevalence of disease-causing beta cardiac MHC mutations to be comparable in all population groups.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8250038      PMCID: PMC1682496     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  20 in total

1.  A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation.

Authors:  A A Geisterfer-Lowrance; S Kass; G Tanigawa; H P Vosberg; W McKenna; C E Seidman; J G Seidman
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

2.  Functions of the myosin ATP and actin binding sites are required for C. elegans thick filament assembly.

Authors:  A Bejsovec; P Anderson
Journal:  Cell       Date:  1990-01-12       Impact factor: 41.582

3.  A molecular basis for familial hypertrophic cardiomyopathy: an alpha/beta cardiac myosin heavy chain hybrid gene.

Authors:  G Tanigawa; J A Jarcho; S Kass; S D Solomon; H P Vosberg; J G Seidman; C E Seidman
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

4.  The CpG dinucleotide and human genetic disease.

Authors:  D N Cooper; H Youssoufian
Journal:  Hum Genet       Date:  1988-02       Impact factor: 4.132

Review 5.  The mutation and polymorphism of the human beta-globin gene and its surrounding DNA.

Authors:  S H Orkin; H H Kazazian
Journal:  Annu Rev Genet       Date:  1984       Impact factor: 16.830

6.  Molecular genetic and genetic correlations in sodium channelopathies: lack of founder effect and evidence for a second gene.

Authors:  J Wang; J Zhou; S M Todorovic; W G Feero; F Barany; R Conwit; I Hausmanowa-Petrusewicz; A Fidzianska; K Arahata; H B Wessel
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

7.  Localization of gene for familial hypertrophic cardiomyopathy to chromosome 14q1 in a diverse US population.

Authors:  J F Hejtmancik; P A Brink; J Towbin; R Hill; L Brink; T Tapscott; A Trakhtenbroit; R Roberts
Journal:  Circulation       Date:  1991-05       Impact factor: 29.690

8.  A locus for familial hypertrophic cardiomyopathy is closely linked to the cardiac myosin heavy chain genes, CRI-L436, and CRI-L329 on chromosome 14 at q11-q12.

Authors:  S D Solomon; A A Geisterfer-Lowrance; H P Vosberg; G Hiller; J A Jarcho; C C Morton; W O McBride; A L Mitchell; A E Bale; W J McKenna
Journal:  Am J Hum Genet       Date:  1990-09       Impact factor: 11.025

9.  Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease.

Authors:  S D Solomon; J A Jarcho; W McKenna; A Geisterfer-Lowrance; R Germain; R Salerni; J G Seidman; C E Seidman
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

10.  The incidence and distribution of CpG----TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspots.

Authors:  P M Green; A J Montandon; D R Bentley; R Ljung; I M Nilsson; F Giannelli
Journal:  Nucleic Acids Res       Date:  1990-06-11       Impact factor: 16.971

View more
  15 in total

Review 1.  Modifier genes for hypertrophic cardiomyopathy.

Authors:  A J Marian
Journal:  Curr Opin Cardiol       Date:  2002-05       Impact factor: 2.161

Review 2.  The molecular genetic basis for hypertrophic cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

3.  To screen or not is not the question--it is when and how to screen.

Authors:  A J Marian; R Roberts
Journal:  Circulation       Date:  2003-05-06       Impact factor: 29.690

4.  Characterization of mutant myosins of Dictyostelium discoideum equivalent to human familial hypertrophic cardiomyopathy mutants. Molecular force level of mutant myosins may have a prognostic implication.

Authors:  H Fujita; S Sugiura; S Momomura; M Omata; H Sugi; K Sutoh
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

5.  Analysis of selected genes associated with cardiomyopathy by next-generation sequencing.

Authors:  Viktoria Szabadosova; Iveta Boronova; Peter Ferenc; Iveta Tothova; Jarmila Bernasovska; Michaela Zigova; Jan Kmec; Ivan Bernasovsky
Journal:  J Clin Lab Anal       Date:  2017-06-08       Impact factor: 2.352

Review 6.  Molecular genetics and pathogenesis of hypertrophic cardiomyopathy.

Authors:  A J Marian; L Salek; S Lutucuta
Journal:  Minerva Med       Date:  2001-12       Impact factor: 4.806

Review 7.  Multiple disease genes cause hypertrophic cardiomyopathy.

Authors:  H Watkins
Journal:  Br Heart J       Date:  1994-12

8.  The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: a unique profile of both independent and founder events.

Authors:  J C Moolman-Smook; W J De Lange; E C Bruwer; P A Brink; V A Corfield
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

9.  Large-scale mutation screening in patients with dilated or hypertrophic cardiomyopathy: a pilot study using DGGE.

Authors:  Raphael Zeller; Boris T Ivandic; Philipp Ehlermann; Oliver Mücke; Christian Zugck; Andrew Remppis; Evangelos Giannitsis; Hugo A Katus; Dieter Weichenhan
Journal:  J Mol Med (Berl)       Date:  2006-05-20       Impact factor: 4.599

10.  Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy.

Authors:  O Roopnarine; L A Leinwand
Journal:  Biophys J       Date:  1998-12       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.